Larry Burgess

Title: Larry Burgess: Innovator in Pharmaceutical Compositions

Introduction

Larry Burgess is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific diseases. His work focuses on innovative solutions that can potentially improve treatment options for patients.

Latest Patents

Larry Burgess holds a patent for "Pharmaceutical compositions comprising WRN helicase inhibitors." This patent discloses compounds of Formula (I) or pharmaceutically acceptable salts or solvates thereof, wherein R, R, X, Y, Z, and W are defined within the patent. The compounds are recognized as inhibitors of WRN helicase and are useful in treating proliferative diseases, such as cancer. He has 1 patent to his name.

Career Highlights

Larry Burgess is currently associated with Vividion Therapeutics, Inc., where he continues to advance his research and development efforts. His work at Vividion Therapeutics focuses on creating innovative therapeutic solutions that address critical health challenges.

Collaborations

Some of his notable coworkers include Shota Kikuchi and Betty Lam, who contribute to the collaborative environment at Vividion Therapeutics. Their combined expertise enhances the potential for groundbreaking discoveries in the pharmaceutical field.

Conclusion

Larry Burgess exemplifies the spirit of innovation in the pharmaceutical industry through his dedicated research and patent contributions. His work has the potential to make a significant impact on the treatment of serious diseases.